Asiri Hospital Holdings PLC (COSE:ASIR.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Asiri Hospital Holdings Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 35,064 | 31,022 | 28,571 | 24,786 | 22,324 | |
Revenue Growth | 13.03% | 8.58% | 15.27% | 11.03% | 41.43% |
Cost of Revenue | 17,313 | 16,315 | 15,024 | 13,119 | 11,923 |
Gross Profit | 17,751 | 14,707 | 13,548 | 11,667 | 10,401 |
Selling, General & Admin | 10,367 | 10,557 | 10,712 | 5,982 | 4,828 |
Operating Expenses | 10,367 | 10,557 | 10,712 | 5,982 | 4,828 |
Operating Income | 7,384 | 4,150 | 2,836 | 5,685 | 5,572 |
Interest Expense | -1,917 | -1,988 | -3,571 | -5,135 | -1,252 |
Interest & Investment Income | 1,563 | 1,259 | 1,648 | 2,437 | 240.13 |
Earnings From Equity Investments | - | 69.31 | 66.99 | 64.78 | - |
Currency Exchange Gain (Loss) | - | 3.46 | -2.2 | 13.61 | 22.58 |
Other Non Operating Income (Expenses) | 304.1 | 159.75 | 157.08 | 131.44 | 183.36 |
EBT Excluding Unusual Items | 7,335 | 3,654 | 1,135 | 3,197 | 4,767 |
Gain (Loss) on Sale of Investments | - | 0.46 | - | 0.43 | 7.08 |
Gain (Loss) on Sale of Assets | - | -2.22 | -2.03 | -2.39 | -1.57 |
Pretax Income | 7,335 | 3,652 | 1,133 | 3,195 | 4,772 |
Income Tax Expense | 2,162 | 1,826 | 1,250 | 1,496 | 968.9 |
Earnings From Continuing Operations | 5,172 | 1,826 | -117.24 | 1,699 | 3,803 |
Minority Interest in Earnings | -305.67 | -182.24 | -97.75 | -230.31 | -299.36 |
Net Income | 4,867 | 1,644 | -214.99 | 1,469 | 3,504 |
Net Income to Common | 4,867 | 1,644 | -214.99 | 1,469 | 3,504 |
Net Income Growth | 196.09% | - | - | -58.08% | 128.83% |
Shares Outstanding (Basic) | 1,137 | 1,138 | 1,138 | 1,138 | 1,138 |
Shares Outstanding (Diluted) | 1,137 | 1,138 | 1,138 | 1,138 | 1,138 |
Shares Change | -0.04% | - | - | - | - |
EPS (Basic) | 4.28 | 1.44 | -0.19 | 1.29 | 3.08 |
EPS (Diluted) | 4.28 | 1.44 | -0.19 | 1.29 | 3.08 |
EPS Growth | 196.20% | - | - | -58.08% | 128.83% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 3,282 | 1,028 | 3,281 | 1,680 | 4,307 |
Free Cash Flow Per Share | 2.89 | 0.90 | 2.88 | 1.48 | 3.79 |
Dividend Per Share | - | 1.500 | - | - | 2.500 |
Dividend Growth | - | - | - | - | 56.25% |
Gross Margin | 50.63% | 47.41% | 47.42% | 47.07% | 46.59% |
Operating Margin | 21.06% | 13.38% | 9.93% | 22.94% | 24.96% |
Profit Margin | 13.88% | 5.30% | -0.75% | 5.93% | 15.70% |
Free Cash Flow Margin | 9.36% | 3.31% | 11.48% | 6.78% | 19.29% |
EBITDA | 9,235 | 5,926 | 4,584 | 7,266 | 6,963 |
EBITDA Margin | 26.34% | 19.10% | 16.04% | 29.32% | 31.19% |
D&A For EBITDA | 1,851 | 1,776 | 1,748 | 1,581 | 1,391 |
EBIT | 7,384 | 4,150 | 2,836 | 5,685 | 5,572 |
EBIT Margin | 21.06% | 13.38% | 9.93% | 22.94% | 24.96% |
Effective Tax Rate | 29.48% | 50.01% | 110.35% | 46.82% | 20.30% |
Advertising Expenses | - | 286.04 | 329.33 | 379.39 | 150.43 |